GGrantIndex
Sort

34,240 grants matching atherosclerosis

Durable Schistosome induced metabolic alterations to the myeloid lineage

$626,956
Keke Celeste Fairfax · University Of Utah · R01 · FY2021 · AI

Epigenetic Determinants of Lipoproteins Across the Early Adult Life Course

$626,944
John Thomas Wilkins · Northwestern University At Chicago · R01 · FY2020 · HL

Preclinical imaging of immune responses to chronic stress

$626,740
Mandy Maria Theresia Van Leent · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL

Epidemiology of Age-Related Hearing Loss

$626,678
Karen J Cruickshanks · University Of Wisconsin-Madison · R01 · FY2006 · AG

Regulation of cell function by mechanical properties of biopolymer networks and lipid bilayers

$626,644
Paul A Janmey · University Of Pennsylvania · R35 · FY2023 · GM

Regulation of cell function by mechanical properties of biopolymer networks and lipid bilayers

$626,644
Paul A Janmey · University Of Pennsylvania · R35 · FY2024 · GM

T helper cells in development of chronic inflammation and multimorbidity

$626,628
Jingzhong Ding · Wake Forest University Health Sciences · R01 · FY2024 · AG

Heart Disease in Rheumatoid Arthritis

$626,482
Sherine E Gabriel · Mayo Clinic Rochester · R01 · FY2007 · AR

Epidemiology: Oxidative Stress and Early Atherosclerosis

$626,433
University Of Minnesota Twin Cities · R01 · FY2005 · HL

MHC-Defined and Identical Twin Monkeys for Research

$626,288
University Of Wisconsin Madison · R24 · FY2002 · RR

Genomic and Metabolomic Profiling of Finnish Familial Dyslipidemia Families

$626,257
Nelson B Freimer · University Of California Los Angeles · R01 · FY2016 · HL

Integrated Proteomic and Metabolomic Determinants of Left Atrial Dysfunction

$626,254
Ravi Bharat Patel · Northwestern University At Chicago · R01 · FY2025 · HL

Metabolic Health Risk Among Mid-Life Women: The Roles of Toxicants, Inflammation, and Epigenetics

$626,183
Karen Eileen Peterson · University Of Michigan At Ann Arbor · R01 · FY2020 · ES

Genetics of atherosclerosis in renal disease

$626,150
Muredach P Reilly · University Of Pennsylvania · R01 · FY2006 · DK

Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment

$626,054
Melina Rae Kibbe · University Of Virginia · R01 · FY2023 · HL

Nck adaptor proteins in atherogenic endothelial activation

$626,038
Anthony Wayne Orr · Louisiana State Univ Hsc Shreveport · R01 · FY2021 · HL

Dual Functionality of Ceramide in Human Microvascular Endothelial Function

$626,030
Julie K Freed · Medical College Of Wisconsin · R01 · FY2025 · HL

A novel essential inflammasome component propagating inflammatory responses

$625,988
Christian Stehlik · Cedars-Sinai Medical Center · R01 · FY2023 · AI

Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial

$625,978
Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2020 · HL

Epidemiology of Age-Related Hearing Loss

$625,972
Karen J Cruickshanks · University Of Wisconsin-Madison · R01 · FY2007 · AG

Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease

$625,883
Jose G Romano · University Of Miami School Of Medicine · R01 · FY2015 · NS

Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV

$625,794
Robert G Weiss · Johns Hopkins University · R56 · FY2014 · HL

Epidemiology of Venous Thrombosis and Pulmonary Embolism

$625,771
Aaron R Folsom · University Of Minnesota · R01 · FY2014 · HL

HIGH FREQUENCY NONLINEAR ACOUSTIC INTRAVASCULAR IMAGING

$625,771
Cleveland Clinic Foundation · R01 · FY2002 · HL

Converge of Pathways Regulating SMC Contractility

$625,732
Avril V. Somlyo · University Of Virginia · P01 · FY2009 · HL